Winner Medical 稳健医疗
9 significant filings since 29 May 2026: 5 on buyback, 2 on dividend and 2 on equity incentive. The latest, on 1 Sep 2026: 关于回购公司股份的进展公告.
自 29 May 2026 起有 9 份重大公告：buyback 5 份、dividend 2 份、equity incentive 2 份。最新一份（1 Sep 2026）：关于回购公司股份的进展公告。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 23 Mar 2025 | 国金证券 | 杨欣,赵中平,袁维,杨雨钦,尹新悦 | Outperform 增持 | ▲ | Buy 买入 |
| 3 Sep 2024 | 国信证券 | 丁诗洁,刘佳琪 | Buy 买入 | ▼ | Outperform 增持 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 国信证券 | 丁诗洁,刘佳琪 | Outperform 增持 | 1 Sep 2026 | 4 | 34.00 |
| 开源证券 | 吕明,郭彬 | Buy 买入 | 30 Aug 2026 | 2 | — |
| 西南证券 | 蔡欣,沈琪 | Buy 买入 | 28 Apr 2026 | 1 | 41.00 |
| 国金证券 | 杨欣,赵中平,杨雨钦 | Buy 买入 | 22 Apr 2026 | 1 | — |
| 东吴证券 | 汤军,赵艺原 | Outperform 增持 | 2 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 5 of 9 reports. 每行为该券商近十二个月的最新研报；9 份中 5 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。